Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 32.20
+1.22 (3.94%)
Dec 5, 2025, 4:09 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 12.86 billion as of December 5, 2025. Its market cap has increased by 475.00% in one year.
Market Cap
12.86B
Enterprise Value
13.01B
Revenue
1.30B
Ranking
n/a
PE Ratio
88.24
Stock Price
32.20
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 12.86B, an increase of 24.69%. That is a compound annual growth rate of 7.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.86B | 278.82% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.02B |
| Hansoh Pharmaceutical Group Company | 244.94B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |